Overview

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.

Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine whether sumanirole is effective and safe in the treatment of the signs and symptoms of early Parkinson's disease.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Ropinirole